< Back to situations

[ORGANIZATION]

Office for Registration of Medicinal Products (URPL)

Featured in 1 tracked story · first seen

Situations

[QUIET] [HEALTH] [PL] [NL]

Pharmaceutical impurity recalls in Poland

2 clusters · 5 sources · last updated

Latest: Polish regulators reject Polpharma application and withdraw Dutilox from market

Polish pharmaceutical regulators have initiated several actions involving the recall and withdrawal of medications due to the presence of nitrosamine impurities, which are potentially carcinogenic. Initially, the Chief